Cell Transfection Services

Inquiry

As a preclinical CRO specializing in oncology, Alfa Cytology provides professional cell transfection services to enable efficient delivery of exogenous genes into tumor cells. Leveraging extensive experience across diverse tumor cell lines and optimized protocols, we ensure high transfection efficiency and robust expression to support your gene function studies, protein production, and cell line engineering.

Introduction to Cell Transfection

Cell transfection is a core technique that introduces exogenous nucleic acids (DNA, RNA, siRNA, mRNA, etc.) into eukaryotic cells through physical, chemical, or biological means, serving as a fundamental tool for gene function studies, disease modeling, and drug target screening. Based on the mode of existence and duration of expression of exogenous nucleic acids in host cells, transfection can be divided into two major types:

Transient Transfection

Exogenous nucleic acids do not integrate into the host cell genome but exist as episomal entities and are gradually lost during cell division. Expression typically peaks at 24–96 hours post-transfection. This approach offers short turnaround time and high expression levels, making it ideal for promoter/enhancer analysis, rapid gene function validation, signaling pathway studies, and small-scale protein production. It is the most widely used transfection method in early-stage drug discovery.

Stable Transfection

Exogenous DNA is integrated into the host cell genome or maintained as episomes for long-term persistence, enabling the target gene to be transmitted to progeny cells during cell division. Antibiotic selection is required to enrich positive clones. This approach supports the construction of engineered cell models including overexpression, gene knockout, and reporter cell lines, and serves as a critical technical foundation for long-term functional studies and IND-enabling research.

Fig. 1 Different transfection protocols that can be divided into viral-based, non-viral based or combination of both (hybrid). (Chong ZX, et al.; 2021)

Our Services

Alfa Cytology provides professional cell transfection services dedicated to delivering your exogenous nucleic acids into target tumor cells with maximum efficiency and reliability. Leveraging extensive transfection experience across a wide range of tumor cell lines and optimized protocols, we ensure that every batch of transfected cells exhibits high transfection efficiency and robust expression levels, providing a solid foundation for your gene function studies, protein expression, and cell engineering applications.

Service Details

We design and optimize transfection strategies tailored to your specific needs, and deliver standardized, quality-controlled services covering the entire workflow from strategy design to expression validation and data delivery.

Service Step	Service Details	Turnaround Time
Transfection Strategy Design	Based on host cell type, nucleic acid type (DNA/siRNA/mRNA), and experimental objectives, we design the optimal transfection strategy. Evaluation of cell type compatibility with various transfection methods Optimization of nucleic acid and transfection reagent ratios Selection of transient or stable transfection strategies	3–5 days
Cell Preparation	Cells are seeded into appropriate culture plates 24 hours prior to transfection to ensure optimal confluence of 60–80% at the time of transfection. Cell counting and viability assessment Selection of appropriate cell density and plate formats Confirmation of cell status before transfection	1–2 days
Transfection Complex Preparation	Nucleic acids and transfection reagents are diluted in serum-free medium, mixed at optimized ratios, and incubated at room temperature for 10–15 minutes to allow transfection complex formation. Optimization of nucleic acid-to-reagent ratios Controlled complex formation conditions Parallel setup of positive and negative controls	1 day
Transfection Execution	The transfection complexes are uniformly dispensed onto cells, gently mixed, and returned to the incubator for continued culture. Uniform distribution of complexes Continuous monitoring of post-transfection cell status Medium replacement at 4–6 hours post-transfection when necessary	1–2 days
Transfection Efficiency Assessment	At 24–72 hours post-transfection, we evaluate transfection efficiency and expression levels using multiple methods. Fluorescence microscopy (for reporter genes) Flow cytometry for quantitative analysis qPCR for mRNA expression analysis Western blot for protein expression analysis	1–2 weeks
Results Delivery	All experimental data and documentation are compiled into a comprehensive report and delivered alongside transfected cells and associated analytical results. Transfection efficiency data Gene/protein expression validation results Complete experimental report	3–5 days

Transfection Method Options

We offer a range of transfection methods tailored to different cell types and experimental requirements:

Lipid-Based Transfection: Cationic lipids form complexes with nucleic acids for endocytic uptake. Suitable for adherent cells and routine tumor cell lines, offering high transfection efficiency.
PEI Transfection: Cationic polymers form nanocomplexes with nucleic acids, protecting them from degradation. Suitable for large-scale transient transfection and cost-effective applications, offering good transfection efficiency.
Electroporation: High-intensity electrical pulses create reversible pores in the cell membrane to facilitate nucleic acid entry. Suitable for suspension cells and hard-to-transfect cell lines, offering high transfection efficiency.
Lentiviral Transduction: Genetically engineered viral particles mediate stable integration of genes into the host cell genome. Suitable for stable cell line construction and hard-to-transfect cells, offering exceptional transfection efficiency (>90%).

Deliverables

Deliverables vary depending on the transfection type selected:

Transient Transfection Deliverables

Transfected cells (cryopreserved or viable)
Untransfected control cells
Transfection efficiency assessment data (fluorescence/flow cytometry)
Gene expression validation data (qPCR/Western blot)
Complete experimental report

Stable Transfection Deliverables

Stably transfected cell line (cryopreserved)
Untransfected control cells
Transfection efficiency and expression validation data
Antibiotic selection records
STR cell line authentication report
Mycoplasma testing report
Complete experimental report

Application

Oncology target rapid validation
Drug mechanism of action (MOA) studies
Gene function overexpression studies
Gene knockdown/knockdown interference (siRNA/shRNA)
Signaling pathway regulation analysis
Pre-evaluation for stable cell line construction
Gene editing efficiency validation (CRISPR/Cas9)
ADC target preliminary assessment

Immuno-oncology research support
Combination therapy preliminary screening
Protein-protein interaction preliminary validation
Promoter/regulatory element analysis
Drug resistance-related gene functional validation
Tumor microenvironment in vitro modeling
Protein expression and small-scale production

Oncology Research Areas

Our cell transfection services are applicable across a wide range of oncology research areas, covering major solid tumors and hematological malignancies. From breast and lung cancer to leukemia and lymphoma, our optimized transfection protocols are designed to meet the specific requirements of various cancer models, supporting your gene function studies, target validation, and cell engineering applications.

With extensive experience in tumor cell transfection and rigorous quality control across every step, Alfa Cytology is your trusted partner for cell transfection services in oncology research. Whether you require rapid gene function validation or long-term stable cell line development, our team is committed to delivering reliable results that propel your drug discovery programs forward. Contact us today to discuss your specific transfection needs.

Reference

Chong ZX, et al. Transfection types, methods and strategies: a technical review. PeerJ. 2021;9:e11165.

For research use only.

Solutions

Online Inquiry

Name *

Email *

Phone *

Services Interested *

Project Description

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.